Hester Biosciences Ltd
Ticker: HESTERBIO
Decent
73/100
☆ Add to Watchlist
Investing Reference
Price
1721.10
Market Cap
1464.12
Debt/Equity
0.6529
ROE %
8.730
PB
4.4821
Promoter %
53.732
Pledge %
0.000
1Y Rev Growth %
-0.213
5Y Rev Growth %
10.970
NP Margin %
8.611
NP Margin 5Y Avg %
11.067
Trading Reference
1M Return %
-16.817
6M Return %
-0.687
1Y Return %
-26.499
% Away 52W High
61.879
% Away 52W Low
38.469
Daily Volume
2510
Investment Verdict
Hold
Score 62/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Hester Biosciences Ltd is currently trading near its support level, with a bullish trend indicated by the 50-day EMA crossing above the 200-day EMA. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable outlook for the next 6-12 months, with potential upside if it breaks through the resistance level.
Upside Probability: 20% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Shanti Educational Initiatives Ltd
Shanti Educational Initiatives Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Q
Quadrant Future Tek Ltd
Quadrant Future Tek Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
V
Vindhya Telelinks Ltd
Vindhya Telelinks Ltd shows potential but faces challenges in growth consistency and market competition.
View details
B
BF Investment Ltd
BF Investment Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sanstar Ltd
Sanstar Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rajratan Global Wire Ltd
Rajratan Global Wire Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability and valuation metrics.
View details
G
Gocl Corporation Ltd
Gocl Corporation Ltd shows potential but faces significant risks and inconsistencies in growth and profitability metrics.
View details
D
Danish Power Ltd
Danish Power Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
E
ECOS (India) Mobility & Hospitality Ltd
ECOS (India) Mobility & Hospitality Ltd shows potential in a future-ready sector but faces challenges in growth consistency and profitability. Caution is advised due to high valuation and execution risks.
View details
J
Jindal Drilling and Industries Ltd
Jindal Drilling and Industries Ltd shows potential in a crucial sector but faces challenges in growth consistency and market valuation.
View details
I
IKIO Technologies Ltd
IKIO Technologies Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
A
Arihant Superstructures Ltd
Arihant Superstructures Ltd shows potential in a growing sector, but faces challenges in execution and market sentiment.
View details
R
Rajoo Engineers Ltd
Rajoo Engineers Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
K
Kesar India Ltd
Kesar India Ltd shows potential but faces several challenges that may limit its growth and profitability in the near term.
View details
R
Ramco Systems Ltd
Ramco Systems Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
B
BLS E-Services Ltd
BLS E-Services Ltd shows several weaknesses in growth, profitability, and valuation metrics, indicating a risky investment.
View details
Business Overview
Hester Biosciences Ltd is a leading Indian biotechnology company specializing in animal health and veterinary vaccines. Catering to the growing needs of farmers and livestock owners, Hester plays a crucial role in enhancing animal productivity and health. With a commitment to innovation and quality, the company contributes significantly to the agricultural sector's sustainability and food security. Hester's robust product portfolio and strong market presence make it a trusted partner in the animal healthcare industry.
- Pioneering veterinary vaccines in India
- Supports farmers and livestock owners
- Focus on animal health and productivity
- Commitment to innovation and quality
- Contributes to food security and sustainability
Investment Thesis
Hester Biosciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning in the biosciences sector make it a promising choice for investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services indicate a robust growth runway in a tech-driven market.
- Attractive valuation metrics compared to industry peers suggest potential upside.
- Established market presence in veterinary and human healthcare sectors.
- Commitment to innovation and R&D positions the company for future growth.
Opportunity vs Risk
Opportunities
- Growing demand for animal vaccines
- Expansion into international markets
- Strong R&D pipeline
- Increasing livestock population in India
- Government support for animal health
Risks ⚠️
- Regulatory changes affecting operations
- High competition in the sector
- Dependence on raw material prices
- Economic downturn impacting sales
- Potential for disease outbreaks affecting livestock
Peer Perspective
Hester Biosciences Ltd trades at a premium compared to peers like Zoetis and Bharat Serums, reflecting its strong growth potential; however, a sustained improvement in margin stability is crucial for further rerating.
Future Outlook
Hester Biosciences Ltd is well-positioned for future growth, driven by increasing demand for its products. However, successful execution and stringent cost control will be crucial to sustain profitability and market expansion.
AI FAQs for Retail Users
- Q: What does Hester Biosciences Ltd do?A: Hester Biosciences Ltd specializes in veterinary vaccines and health products for livestock and poultry.
- Q: Is Hester Biosciences Ltd a profitable company?A: The company has shown profitability in recent years, but past performance does not guarantee future results.
- Q: What are the risks of investing in Hester Biosciences Ltd?A: Risks include market competition, regulatory changes, and fluctuations in demand for veterinary products.
- Q: How can I buy shares of Hester Biosciences Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What is the company's growth potential?A: Growth potential depends on market conditions, product development, and expansion strategies.
📊 Stock Investment Checklist (100 Points)
Hester Biosciences Ltd • Updated: 2025-09-17 02:25:02
-
10BusinessHighThe company operates in the veterinary healthcare sector, which is growing due to increasing pet ownership and livestock health awareness.
-
10GrowthHighConsistent revenue growth over the past few years, but profit growth has been variable.
-
10ProfitabilityHighROE and ROCE are decent, but OCF has shown some fluctuations compared to net profit.
-
8ValuationHighP/E and P/B ratios are higher than industry averages, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios suggest some caution.
-
6GovernanceGoodPromoter holding is strong, but there are some concerns regarding disclosures.
-
10DriversHighGrowth drivers include expanding product lines and increasing market penetration.
-
5TechnicalsGoodMarket sentiment is mixed, with some recent volatility in price action.
Final Score & Verdict
Score 73 / 100
• Decent
Hester Biosciences Ltd shows potential for growth in a favorable sector, but faces challenges in profitability consistency and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 75/100